Jean-Paul St-Pierre
Geen lopende functies
Loopbaan van Jean-Paul St-Pierre
Eerdere bekende functies van Jean-Paul St-Pierre
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Directeur/Bestuurslid | 07-12-2007 | 31-03-2010 |
| Hoechst Marion Roussel Canada, Inc. | Hoofd Techniek/Wetenschap/O&O | - | - |
| Rhône-Poulenc, Inc. | Hoofd Techniek/Wetenschap/O&O | - | - |
Synapse Technologies, Inc.
 Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | President | - | - |
Sandoz Canada, Inc.
 Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Jean-Paul St-Pierre
| University of Montréal | Doctorate Degree |
Statistieken
Internationaal
| Canada | 6 |
| Verenigde Staten | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Sandoz Canada, Inc.
Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Health Technology |
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Health Technology |
| Rhône-Poulenc, Inc. | Process Industries |
| Hoechst Marion Roussel Canada, Inc. |
- Beurs
- Insiders
- Jean-Paul St-Pierre
- Ervaring
